JP2000507568A5 - - Google Patents

Download PDF

Info

Publication number
JP2000507568A5
JP2000507568A5 JP1997535066A JP53506697A JP2000507568A5 JP 2000507568 A5 JP2000507568 A5 JP 2000507568A5 JP 1997535066 A JP1997535066 A JP 1997535066A JP 53506697 A JP53506697 A JP 53506697A JP 2000507568 A5 JP2000507568 A5 JP 2000507568A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997535066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000507568A (ja
Filing date
Publication date
Priority claimed from GBGB9607035.4A external-priority patent/GB9607035D0/en
Application filed filed Critical
Publication of JP2000507568A publication Critical patent/JP2000507568A/ja
Publication of JP2000507568A5 publication Critical patent/JP2000507568A5/ja
Pending legal-status Critical Current

Links

JP9535066A 1996-04-03 1997-04-03 遺伝子療法に用いる治療用ビヒクルとしての噴霧乾燥微粒子 Pending JP2000507568A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
WO9607035.4 1996-06-07
GB9601379 1996-06-07
WO96/01379 1996-06-07
PCT/GB1997/000953 WO1997036578A1 (en) 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Publications (2)

Publication Number Publication Date
JP2000507568A JP2000507568A (ja) 2000-06-20
JP2000507568A5 true JP2000507568A5 (cg-RX-API-DMAC7.html) 2004-12-09

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9535066A Pending JP2000507568A (ja) 1996-04-03 1997-04-03 遺伝子療法に用いる治療用ビヒクルとしての噴霧乾燥微粒子

Country Status (14)

Country Link
EP (1) EP0936902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000507568A (cg-RX-API-DMAC7.html)
AR (1) AR007493A1 (cg-RX-API-DMAC7.html)
AT (1) ATE243027T1 (cg-RX-API-DMAC7.html)
AU (1) AU715512B2 (cg-RX-API-DMAC7.html)
CA (1) CA2250478A1 (cg-RX-API-DMAC7.html)
DE (1) DE69722952T2 (cg-RX-API-DMAC7.html)
DK (1) DK0936902T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201283T3 (cg-RX-API-DMAC7.html)
GB (1) GB9607035D0 (cg-RX-API-DMAC7.html)
NO (1) NO984462D0 (cg-RX-API-DMAC7.html)
PT (1) PT936902E (cg-RX-API-DMAC7.html)
WO (1) WO1997036578A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA972837B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JP2000500744A (ja) 1995-11-09 2000-01-25 マイクロバイオロジカル リサーチ オーソリティー ワクチン接種および遺伝子治療のためのマイクロカプセル化dna
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
CA2942128C (en) 2006-08-04 2019-11-26 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8808747B2 (en) 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
EP3826608A1 (en) * 2018-07-23 2021-06-02 Translate Bio, Inc. Dry power formulations for messenger rna
EP3908264A1 (en) * 2019-01-09 2021-11-17 Ziccum AB Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
ATE204750T1 (de) * 1992-06-12 2001-09-15 Teijin Ltd Pharmazeutische zubereitung zur anwendung in den atemwegen
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
WO1994023699A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
ES2245780T3 (es) * 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
MX9702357A (es) * 1994-09-29 1997-06-28 Andaris Ltd Microparticulas secadas por aspersion como vehiculos terapeuticos.
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
CA2227287A1 (en) * 1995-07-21 1997-02-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles

Similar Documents

Publication Publication Date Title
JP2000501599A5 (cg-RX-API-DMAC7.html)
JP2000501018A5 (cg-RX-API-DMAC7.html)
JP2000500076A5 (cg-RX-API-DMAC7.html)
JP2000509299A5 (cg-RX-API-DMAC7.html)
JP2000516683A5 (cg-RX-API-DMAC7.html)
JP2000501324A5 (cg-RX-API-DMAC7.html)
JP2001524993A5 (cg-RX-API-DMAC7.html)
JP2001504717A5 (cg-RX-API-DMAC7.html)
JP2000502472A5 (cg-RX-API-DMAC7.html)
JP2000501338A5 (cg-RX-API-DMAC7.html)
JP2000500874A5 (cg-RX-API-DMAC7.html)
JP2000502568A5 (cg-RX-API-DMAC7.html)
JP2000500912A5 (cg-RX-API-DMAC7.html)
JP2000502570A5 (cg-RX-API-DMAC7.html)
JP2000509294A5 (cg-RX-API-DMAC7.html)
JP2000501744A5 (cg-RX-API-DMAC7.html)
JP2000507239A5 (cg-RX-API-DMAC7.html)
JP2000501229A5 (cg-RX-API-DMAC7.html)
JP2000500857A5 (cg-RX-API-DMAC7.html)
JP2000502714A5 (cg-RX-API-DMAC7.html)
JP2000501569A5 (cg-RX-API-DMAC7.html)
JP2000500184A5 (cg-RX-API-DMAC7.html)
JP2000507568A5 (cg-RX-API-DMAC7.html)
JP2001506478A5 (cg-RX-API-DMAC7.html)
JP2001504407A5 (cg-RX-API-DMAC7.html)